Imaging With a New Agent That Finds a Cancer Protein Called HER2

Summary

The purpose of this study is to test if an imaging agent called Zr-DFO-pertuzumab that finds HER2 proteins can be used to take pictures of HER2-positive cancer.

Timeline

Start

2017-03-31

Primary completion

2018-04-12

Completion

2018-04-12

Drugs

Indications